(Q53365502)

English

A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine.

scientific article

Statements

A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit